Ian Michael Estepan - 29 Jan 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Chief Financial Officer
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Ian M. Estepan
Issuer symbol
SRPT
Transactions as of
29 Jan 2025
Transactions value $
-$117,454
Form type
4
Filing time
31 Jan 2025, 20:30:04 UTC
Previous filing
30 Dec 2024
Next filing
13 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Options Exercise $171K +14.3K +42.34% $12.00 48K 29 Jan 2025 Direct
transaction SRPT Common Stock Options Exercise $18.4K +1.53K +3.2% $12.00 49.5K 29 Jan 2025 Direct
transaction SRPT Common Stock Tax liability -$307K -2.61K -5.28% $117.51 46.9K 29 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Stock Option (right to buy) Options Exercise $0 -14.3K -100% $0.00 0 29 Jan 2025 Common Stock 14.3K $12.00 Direct
transaction SRPT Stock Option (right to buy) Options Exercise $0 -1.53K -100% $0.00 0 29 Jan 2025 Common Stock 1.53K $12.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax witholding obligations and payment by the Reporting Person of the option exercise price. The Reporting Person holds the exercised shares not withheld by the Issuer.